Search - tctmd.com

Displaying 361 - 380 of 4646

Sort: Relevancy | Date

Presentation THT 2025

Good vs Bad Calcium: Safely Increasing Contractility With Increased Calcium Influx

Presenter: Steven Marx

February 12, 2025

Presentation THT 2025

Overview of Gene Therapy: Vectors, Modes of Delivery and Immunosuppression

Presenter: Joe Rossano

February 12, 2025

Presentation THT 2025

Gene Therapy to Reverse Acquired Cardiomyopathy and Recover Chronic Heart Failure

Presenter: Robin Shaw

February 12, 2025

Presentation THT 2025

Gene Therapy for Monogenic Disorders: Current and Pending Studies

Presenter: Barry Greenberg

February 12, 2025

Presentation THT 2025

Stem Cell Based Therapies for HFpEF and HFrEF

Presenter: Sunjay Kushal

February 12, 2025

Presentation THT 2025

Baroceptor Activation Therapy

Presenter: Shelley Hall

February 12, 2025

Presentation THT 2025

Cardiac Contractility Modulation Across the Spectrum of EFs

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Transcatheter Left Ventricular Restoration: Ancora System

Presenter: Ulrich Jorde

February 12, 2025

Presentation THT 2025

The Carillon Mitral Contour System

Presenter: Samir Kapadia

February 12, 2025

Presentation THT 2025

Myocardial Intramural Remodeling by Transvenous Tether (MIRTH)

Presenter: Chris Bruce

February 12, 2025

Presentation THT 2025

Diaphragmatic Stimulation - Viscardia

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Greater Splanchnic Nerve Ablation for HFpEF

Presenter: Sheldon Litwin

February 12, 2025

Presentation THT 2025

Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Controlled Pulmonary Artery Banding for HFrEF (Restore Medical)

Presenter: Sean Pinney

February 12, 2025

Presentation THT 2025

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Presenter: Nir Uriel

February 12, 2025

Presentation THT Abstracts 2025

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Presenter: John Mohr

February 11, 2025

Presentation THT 2025

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Presenter: John Mohr

February 11, 2025

Presentation THT 2025

Will Novel Catheter Based Approaches Save the Day?

Presenter: Jaffar Khan

February 11, 2025

Presentation THT 2025

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Presenter: Giada Bianchi

February 11, 2025

Presentation THT 2025

Session Introduction: Novel Frontiers in HFpEF Diagnostics and Management

Presenter: Kavita Sharma

February 11, 2025

Advertisement

Good vs Bad Calcium: Safely Increasing Contractility With Increased Calcium Influx

Overview of Gene Therapy: Vectors, Modes of Delivery and Immunosuppression

Gene Therapy to Reverse Acquired Cardiomyopathy and Recover Chronic Heart Failure

Gene Therapy for Monogenic Disorders: Current and Pending Studies

Stem Cell Based Therapies for HFpEF and HFrEF

Baroceptor Activation Therapy

Cardiac Contractility Modulation Across the Spectrum of EFs

Transcatheter Left Ventricular Restoration: Ancora System

The Carillon Mitral Contour System

Myocardial Intramural Remodeling by Transvenous Tether (MIRTH)

Diaphragmatic Stimulation - Viscardia

Greater Splanchnic Nerve Ablation for HFpEF

Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF

Controlled Pulmonary Artery Banding for HFrEF (Restore Medical)

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Subcutaneous (SC) Injection of a Novel-Formulation of Furosemide (FUR) Administered via an Autoinjector

Will Novel Catheter Based Approaches Save the Day?

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Session Introduction: Novel Frontiers in HFpEF Diagnostics and Management

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content